AU2016202399A1 - Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to EGFR kinase inhibitor in tumours or tumour cells - Google Patents

Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to EGFR kinase inhibitor in tumours or tumour cells

Info

Publication number
AU2016202399A1
AU2016202399A1 AU2016202399A AU2016202399A AU2016202399A1 AU 2016202399 A1 AU2016202399 A1 AU 2016202399A1 AU 2016202399 A AU2016202399 A AU 2016202399A AU 2016202399 A AU2016202399 A AU 2016202399A AU 2016202399 A1 AU2016202399 A1 AU 2016202399A1
Authority
AU
Australia
Prior art keywords
tumours
epithelial
response
kinase inhibitor
tumour cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016202399A
Inventor
Thomas M. Holcomb
David SHAMES
Kimberly Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2016202399A1 publication Critical patent/AU2016202399A1/en
Abandoned legal-status Critical Current

Links

AU2016202399A 2011-09-30 2016-04-15 Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to EGFR kinase inhibitor in tumours or tumour cells Abandoned AU2016202399A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/542,141 2011-09-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2012321248A Division AU2012321248A1 (en) 2011-09-30 2012-09-28 Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to EGFR kinase inhibitor in tumours or tumour cells

Publications (1)

Publication Number Publication Date
AU2016202399A1 true AU2016202399A1 (en) 2016-05-12

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110846404A (en) * 2019-11-21 2020-02-28 深圳市龙华区人民医院 Application of PKP3 gene methylation in sperm motility detection agent and kit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110846404A (en) * 2019-11-21 2020-02-28 深圳市龙华区人民医院 Application of PKP3 gene methylation in sperm motility detection agent and kit

Similar Documents

Publication Publication Date Title
IL231590A0 (en) Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to egfr kinase inhibitor in tumours or tumour cells
HK1205123A1 (en) Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors - fgfr
EP2616442B8 (en) Inhibitors of pi3k-delta and methods of their use and manufacture
EP2569633A4 (en) Compositions and methods of identifying tumor specific neoantigens
IL231813B (en) Use composition comprising atr inhibitors for the treatment of pancreatic cancer and non-small cell lung cancer
EP2638149A4 (en) Immortalization of epithelial cells and methods of use
AU2014227804B2 (en) Serum-free cell culture medium
PT3111950T (en) Methods and compositions related to glucocorticoid receptor antagonism and prostate cancer
GB201100180D0 (en) Tumour cell and tissue culture
EP2742123A4 (en) Isolation and detection of cancer cells
EP2547698A4 (en) Methods of determining susceptibility of tumors to tyrosine kinase inhibitors
ZA201204793B (en) Substituted naphthyridines and their use as syk kinase inhibitors
HK1201194A1 (en) Composition of detection agents for epithelial tumour cells and preparation method therefor
EP2748337A4 (en) Cell response assay for cancer and methods of producing and using same
HK1202809A1 (en) Mammalian fetal pulmonary cells and therapeutic use of same
EP2558599A4 (en) Methods of evaluating response to cancer therapy
EP2555801A4 (en) Selection and use of host cells for production of glycoproteins
EP2611943A4 (en) Methods and compositions for correlating genetic markers with prostate cancer risk
PT2910567T (en) Asparaginic acid kinase iii mutant and host cells and use thereof
SG11201502497RA (en) Sebocyte cell culturing and methods of use
IL230545A0 (en) Detection of prame gene expression in cancer
EP3022306A4 (en) Methods of improving titer in transfection-based production systems using eukaryotic cells
AU2016202399A1 (en) Diagnostic methylation markers of epithelial or mesenchymal phenotype and response to EGFR kinase inhibitor in tumours or tumour cells
EP2841556A4 (en) Compositions and methods for modulating the sensitivity of cells to ahas inhibitors
GB201112637D0 (en) The process of nanostenting and nanomeshing cancer cells